Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
The Autism Impact Fund (AIF) is a healthcare technology and innovation venture capital firm founded in 2020. Based in the United States, AIF focuses on investing in behavioral health, mental health, autism, and complex chronic conditions. The firm was established to address the fragmented and outdated systems that families encounter when seeking support for autism and related conditions. AIF aims to revolutionize treatment through strategic investments in early- and growth-stage companies.
As of now, AIF manages a $60 million fund and has built a portfolio of eight companies. The firm is actively expanding its reach and influence in the healthcare sector, particularly in areas that require urgent innovation. AIF's commitment to addressing the challenges families face in accessing support is evident in its investment strategy, which emphasizes technology-enabled solutions and value-based care models.
AIF invests in early- and growth-stage companies that are innovating in the fields of behavioral health, mental health, and complex chronic conditions. The firm targets sectors such as diagnostics, digital health, therapeutics, and care delivery. AIF emphasizes the need to address gaps and inefficiencies in these markets, which represent a significant economic opportunity. The firm typically invests between $100,000 and $5 million, with a sweet spot around $1.5 million.
The investment strategy includes a focus on technology and AI-enabled solutions for autism care, as well as broader behavioral and mental health solutions for co-occurring conditions. AIF seeks to partner with founders who are committed to improving treatment outcomes for neurodivergent individuals and who demonstrate a clear understanding of the challenges within the healthcare system.
AIF's portfolio includes several notable companies that are making significant strides in healthcare technology:
These companies represent AIF's commitment to addressing the needs of families navigating complex health challenges, particularly in the autism and behavioral health sectors.
Christopher Male: Co-Founder & Managing Partner. Christopher has extensive experience in healthcare investment and has led multiple successful ventures in the sector.
Brian O'Callaghan: Co-Founder. Brian brings a wealth of knowledge in behavioral health and has been instrumental in shaping AIF's investment strategy.
Robert Sarrazin: Chief Investment Officer & Managing Partner. Robert has a strong background in venture capital and has overseen numerous successful investments in healthcare technology.
Ashok Srinivasan: Chief Science Advisor. Ashok provides scientific expertise and guidance, ensuring that AIF's investments are grounded in solid research and innovation.
Robbie Allen: Operating Partner. Robbie focuses on operational support for portfolio companies, helping them scale effectively.
Lauren Ingram: Principal. Lauren plays a key role in sourcing and evaluating new investment opportunities within the healthcare sector.
Dan Tarman: Chief Communications Officer. Dan manages AIF's public relations and communications strategy, enhancing the firm's visibility in the market.
Michelle He: Senior Associate. Michelle supports the investment team in due diligence and portfolio management.
Nikhita Kulkarni: Associate, Investments & Investor Relations. Nikhita assists in managing investor relations and sourcing new investment opportunities.
To pitch AIF, founders should visit the firm's website at autismimpact.fund. A well-structured pitch deck should include an overview of the business model, market opportunity, competitive landscape, and financial projections. AIF prefers pitches that demonstrate a clear understanding of the challenges within the healthcare system and how their solution addresses these issues. Response times can vary, but founders should expect to hear back within a few weeks of submission.
In 2023, AIF announced the successful closing of its first fund at $60 million, focusing on healthcare technology investments. The firm has actively built its portfolio since its founding, with notable investments in companies like Auticon and BioROSA.
Additionally, AIF has secured $10 million for its second fund from Fairfield-Maxwell Ltd., indicating strong investor confidence in its mission and strategy. The firm continues to expand its portfolio, targeting innovative solutions for autism and mental health.
What are AIF's investment criteria?
AIF focuses on early- and growth-stage companies innovating in behavioral health, mental health, and complex chronic conditions, particularly those related to autism. The firm looks for technology-enabled solutions that address systemic gaps in care.
How can I apply or pitch to AIF?
Founders can submit their pitches through the AIF website at autismimpact.fund. It is recommended to include a clear business model, market analysis, and details on how the solution addresses specific challenges in the healthcare sector.
What makes AIF different from other venture capital firms?
AIF specializes in the autism and behavioral health sectors, focusing on technology and innovation to improve treatment outcomes. The firm emphasizes partnerships and strategic support for its portfolio companies.
What is AIF's geographic scope?
AIF primarily invests in companies based in the United States, targeting innovations that can significantly impact the healthcare landscape.
What is the typical check size for investments?
AIF invests between $100,000 and $5 million, with a sweet spot around $1.5 million, allowing for flexibility based on the needs of the portfolio companies.
What is AIF's involvement post-investment?
AIF provides strategic support to its portfolio companies through partnerships, industry expertise, and access to a network of healthcare professionals and organizations, enhancing their growth potential.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.